Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

On July 24, 2025, the PTO Acting Director Coke Morgan Stewart discretionarily denied Amgen’s IPR2025-00601 and IPR2025-00602 challenging ...

A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

President Trump sent letters Thursday to 17 of the world’s largest drug companies, telling them to take more steps to slash ...

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

As August 5 approaches, Amgen (AMGN) gears up to reveal its Q2 2025 earnings after market close, and expectations are high ...

We expect Amgen AMGN to beat expectations when it reports second-quarter 2025 results on Aug. 5 after market close. In the ...

Valley Wealth Managers Inc. just upped their Amgen game by 8.1% this quarter, now holding a cool $27.15 million worth of ...